Transdermal Estradiol Gel Prescription Guidelines for Postmenopausal Women

Initial Dosing Strategy

The American College of Obstetricians and Gynecologists recommends starting with 0.5-0.75 mg of transdermal estradiol gel applied daily to clean, dry skin on the lower abdomen, upper outer arm, or thighs, and if the patient has an intact uterus, adding micronized progesterone 200 mg orally for 12-14 days every 28 days to prevent endometrial cancer 1, 2
The effective dose range for transdermal gel is 0.5-1 mg daily, which is approximately equivalent to a 50 mcg/24-hour transdermal patch 1, 2

The American College of Obstetricians and Gynecologists recommends adding progestin supplementation if the patient has a uterus to prevent endometrial hyperplasia and cancer 1, 2
First-line: Micronized progesterone 200 mg orally (or vaginally) for 12-14 days every 28 days (sequential regimen) 1, 2, 3

Reassess symptom control after 2-3 months on the initial dose 1, 2
If vasomotor symptoms persist after 2-3 months on 0.5 mg daily, increase to 0.75 mg daily 1

The US Preventive Services Task Force recommends against prescribing estrogen therapy solely for prevention of chronic conditions (cardiovascular disease, osteoporosis, dementia) in asymptomatic postmenopausal women due to increased risks of stroke, dementia, gallbladder disease, and breast cancer that outweigh fracture reduction benefits 4
Transdermal estradiol has a neutral effect on venous thromboembolism risk (OR 0.9), whereas oral estradiol significantly increases VTE risk (OR 4.2) 2
Blood pressure and metabolic profiles are more favorable with transdermal versus oral estradiol 2

Never start with high doses (>1 mg daily) as initial therapy—evidence shows no additional benefit and increased harm 3
Do not forget progestin opposition in women with an intact uterus—this is the most critical error that leads to endometrial cancer 1, 2